Common questions about Valtoco (FAQ)
Q: Is Valtoco the same type of medication as Diastat?
Valtoco (diazepam nasal spray) and Diastat (diazepam rectal gel) both contain the same active pharmaceutical ingredient, diazepam. According to official sources, both are indicated for the acute treatment of seizure clusters.
Q: Does Valtoco cause extreme sleepiness?
Official information states that somnolence (drowsiness or sleepiness) is one of the most common adverse reactions reported in studies. The medication also carries a warning regarding the risk of profound sedation when it is used at the same time as opioids or other Central Nervous System (CNS) depressants.
Q: Are there any food or drinks that should be avoided when using Valtoco?
Official guidance indicates that consuming alcoholic beverages and grapefruit or grapefruit juice should be discussed with a healthcare provider. Alcohol can increase the severity of side effects, while grapefruit products may increase the amount of medication in the body.
Q: Is it safe to use Valtoco if I am taking certain antidepressants?
Valtoco's active ingredient is processed by specific liver enzymes known as CYP2C19 and CYP3A4. Taking certain other medications, including some antidepressants, that block these enzymes may decrease how quickly Valtoco leaves the body, potentially increasing systemic exposure. Regulatory documents state that patients must inform their healthcare provider of all prescription and nonprescription medications.
Q: Can I use Valtoco if I have a history of certain breathing problems?
The official Medication Guide recommends patients discuss a history of certain respiratory conditions, such as asthma, emphysema, bronchitis, chronic obstructive pulmonary disease, or other breathing problems, with their healthcare provider before use.
Q: Can Valtoco be given while a patient is lying down or must they be sitting up?
According to official usage information, the nasal spray device can be used safely with the patient's head in any position during administration.
Q: Can a patient who is pregnant or breastfeeding use Valtoco?
Official information indicates that taking the medication late in pregnancy may cause symptoms of sedation or withdrawal in the newborn. Additionally, the active ingredient passes into breast milk and may lead to sleepiness or feeding problems in the infant.
Q: What is the risk of overdose with Valtoco?
Symptoms that may be associated with an overdose of diazepam include drowsiness, confusion, unsteadiness, or coma. Official warnings state that the risk of fatal overdose is significantly increased when this medication is taken with alcohol, opioid medicines, or other drugs that cause drowsiness or slow breathing.
Q: Are there different strengths of Valtoco available?
The official prescribing information indicates that the medication is available in four fixed total doses: 5 mg, 10 mg, 15 mg, and 20 mg.
Q: Why is Valtoco given as a nasal spray instead of a pill?
Valtoco is formulated as a specialized intranasal spray that incorporates a permeation enhancer. This formulation is designed to achieve rapid and consistent absorption of the active ingredient into the body for immediate-use acute treatment.
Q: How long does it take for Valtoco to start working after administration?
Studies and official information indicate that the medication is fast-acting. In clinical research where the medication was administered early in the seizure episode, the median time to seizure cessation (the stopping of seizure activity) was reported to be 2 minutes.
Q: Does using Valtoco affect my ability to drive after the cluster seizure is over?
Official warnings state that Valtoco can cause sleepiness, dizziness, and slow a person’s thinking and motor skills. Driving or operating heavy machinery must be avoided until the patient knows how the medication affects them and the effects, such as drowsiness, have fully subsided.
Q: What makes Valtoco different from other rescue seizure medicines?
Valtoco is distinguished by its intranasal delivery system. The FDA designated the formulation as having a significantly improved ease of use compared to the established rectal gel formulation of diazepam, which contributed to its distinction.
Q: Is it normal to feel a burning sensation in the nose after using Valtoco?
Common adverse reactions reported in clinical studies include Nasal Discomfort, which covers various local sensations that may occur at the administration site, such as irritation or rhinorrhea.
Q: Are there any known long-term effects associated with using Valtoco as needed?
Official documents state that long-term effects for this specific formulation are not fully established. Long-term safety studies primarily monitored usage patterns and how well the nose tolerated the spray over time.
Q: Can Valtoco cause confusion or memory issues?
Regulatory documents report that confusion and memory problems have been reported as symptoms of overdose. Additionally, if the medication is suddenly stopped after frequent use, potential withdrawal symptoms may include trouble remembering or concentrating.
Q: Why is Valtoco considered a 'rescue' therapy?
Valtoco is considered a seizure rescue medication because it is a fast-acting product given as needed and immediately at the first sign of an episode. Its purpose is to actively intervene and stop frequent seizure activity.
Q: Does Valtoco interact with hormonal birth control?
The medication is processed by the CYP2C19 and CYP3A4 enzymes in the liver. Agents, including some forms of hormonal birth control, that induce these enzymes may increase the elimination of the drug, potentially resulting in decreased systemic exposure. Patients must inform their healthcare provider of all prescription medications.
Q: Is Valtoco available as a generic medicine?
According to public regulatory information in the United States, there is currently no generic version of Valtoco (diazepam nasal spray) available.
Q: Do studies suggest Valtoco's absorption rate is faster than oral diazepam?
Studies that measured the time to reach maximum plasma concentration (t max) for Valtoco reported values that were generally slower than those reported for oral diazepam in fasted individuals.
Q: What are the signs that Valtoco may be working?
The medication is indicated to stop seizure activity. In clinical studies, success was often defined by seizure cessation (the stopping of the seizure) within a short time after administration.
Q: Does Valtoco have a warning about potential changes in mood or behavior?
Like other antiepileptic drugs, Valtoco carries a warning regarding the risk of suicidal thoughts or actions. Official documents advise monitoring for the emergence or worsening of depression, and/or unusual changes in mood or behavior.
Q: Does Valtoco contain any ingredients that cause allergic reactions?
The medication is contraindicated (should not be used) if a patient has a known hypersensitivity to diazepam or any other component of the formulation. Discussion of all known allergies with a healthcare provider is noted in regulatory documents.
Q: What clinical evidence supports the use of Valtoco in emergency situations?
Clinical approval was based primarily on comparative bioavailability studies. These studies demonstrated that the medication achieved systemic exposure of diazepam similar to that of the existing, approved rectal gel formulation.
